[1] Partsch H. Varicose veins and chronic venous insufficiency. VASA Zeitschrift für Gefässkrankheiten Journal for vascular diseases. 2009;38:293-301. https://doi.org/10.1024/0301-1526.38.4.293
[2] Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2014;130:333-46. https://doi.org/10.1161/CIRCULATIONAHA.113.006898
[3] Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Annals of epidemiology. 2005;15:175-84. https://doi.org/10.1016/j.annepidem.2004.05.015
[4] Piazza G. Varicose veins. Circulation. 2014;130:582-7. https://doi.org/10.1161/CIRCULATIONAHA.113.008331
[5] Baliyan V, Tajmir S, Hedgire SS, Ganguli S, Prabhakar AM. Lower extremity venous reflux. Cardiovasc Diagn Ther. 2016;6:533-43. http://dx.doi.org/10.21037/cdt.2016.11.14
[6] Black, C. M. “Anatomy and Physiology of the Lower-Extremity Deep and Superficial Veins.” Techniques in Vascular & Interventional Radiology 2014;17(2): 68-73. https://doi.org/10.1053/j.tvir.2014.02.002
[7] Delis KT, Knaggs AL, Khodabakhsh P. Prevalence, anatomic patterns, valvular competence, and clinical significance of the Giacomini vein. Journal of Vascular Surgery. 2004;40:1174-83. https://doi.org/10.1016/j.jvs.2004.09.019
[8] Ricci S. 1 – Anatomy. In: Goldman MP, Weiss RA, editors. Sclerotherapy (Sixth Edition): Elsevier; 2017. p. 1-26. https://doi.org/10.1016/B978-0-323-37726-3.00001-0
[9] Anwar MA, Georgiadis KA, Shalhoub J, Lim CS, Gohel MS, Davies AH. A Review of Familial, Genetic, and Congenital Aspects of Primary Varicose Vein Disease. Circulation: Cardiovascular Genetics. 2012;5:460-6. https://doi.org/10.1161/CIRCGENETICS.112.963439
[10] Lurie, F., et al. “The 2020 update of the CEAP classification system and reporting standards.” J Vasc Surg Venous Lymphat Disord 2020;8(3): 342-352. https://doi:10.1016/j.jvsv.2019.12.075
[11] Wittens C, Davies AH, Bækgaard N, Broholm R, Cavezzi A, Chastanet S, et al. Management of Chronic Venous Disease: Clinical Practice Guidelines of the European Society for Vascular Surgery (ESVS). European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery. 2015;49:678-737. https://doi.org/10.1016/j.ejvs.2015.02.0070
[12] Masuda E, Ozsvath K, Vossler J, Woo K, Kistner R, Lurie F, et al. The 2020 appropriate use criteria for chronic lower extremity venous disease of the American Venous Forum, the Society for Vascular Surgery, the American Vein and Lymphatic Society, and the Society of Interventional Radiology. Journal of Vascular Surgery: Venous and Lymphatic Disorders. 2020;8:505-25.e4. https://doi.org/10.1016/j.jvsv.2020.02.001
[13] Parsi K, Roberts S, Kang M, Benson S, Baker L, Berman I, et al. Cyanoacrylate closure for peripheral veins: Consensus document of the Australasian College of Phlebology. Phlebology. 2020;35:153-75. https://doi.org/10.1177/0268355519864755
[14] Gohel MS, Mora M, Jocelyn, Szigeti M, Epstein DM, Heatley F, Bradbury A, et al. Long-term Clinical and Cost-effectiveness of Early Endovenous Ablation in Venous Ulceration: A Randomized Clinical Trial. JAMA Surgery. 2020. https://doi.org/10.1001/jamasurg.2020.3845
[15] Martinez-Zapata MJ, Vernooij RW, Simancas-Racines D,Uriona Tuma SM, Stein AT, Moreno RM, Vargas E, et al. Phlebotonics for venous insufficiency. Cochrane Database of Systematic Reviews. 2020;11(11):CD003229. https://doi.10.1002/14651858.CD003229.pub4
[16] Whing, J., et al. (2021). “Interventions for great saphenous vein incompetence.” Cochrane Database of Systematic Reviews(8). https://doi.org//10.1002/14651858.CD005624.pub4
[17] Morrison N, Gibson K, Vasquez M, Weiss R, Jones A. Five-year extension study of patients from a randomized clinical trial (VeClose) comparing cyanoacrylate closure versus radiofrequency ablation for the treatment of incompetent great saphenous veins. Journal of vascular surgery Venous and lymphatic disorders. 2020;8:978-89. https://doi.org/10.1016/j.jvsv.2019.12.080
[18] Rabe E, Breu F, Cavezzi A, Smith PC, Frullini A, Gillet J, et al. European guidelines for sclerotherapy in chronic venous disorders. Phlebology. 2014;29:338-54. https://journals.sagepub.com/doi/abs/10.1177/0268355513483280